Table 1.
Distribution of socio-demographic and epidemiological characteristics in HIV-positive patients according to HCV status.
| Variable | Total (n = 148) |
HCV-negative (n = 132) |
HCV-positive (n = 16) |
p |
|---|---|---|---|---|
| Male gender | 67 (45.2) | 58 (43.9) | 9 (56.3) | 0.428 |
| Age (years) | 41.9 ± 11.9 | 41.9 ± 12.2 | 41.6 ± 8.7 | 0.898 |
| Education level | 0.829 | |||
| Complete primary education or less | 109 (73.6) | 97 (73.5) | 12 (75.0) | |
| Secondary or higher education | 39 (26.3) | 35 (26.5) | 4 (25.0) | |
| Sexual orientationa | 0.947 | |||
| Heterosexual | 136 (91.8) | 120 (90.9) | 16 (100.0) | |
| Homosexual | 6 (4.0) | 6 (4.5) | – | |
| Bisexual | 5 (3.3) | 5 (3.8) | – | |
| Possible forms of HIV infectiona,b | ||||
| Sex | 127 (85.8) | 112 (84.8) | 15 (93.8) | 0.577 |
| Blood transfusion | 7 (4.7) | 6 (4.5) | 1 (6.3) | 0.931 |
| Cutting objects | 2 (1.3) | 2 (1.5) | – | 0.878 |
| Sharing needles | 5 (3.3) | 1 (0.8) | 4 (25.0) | <0.001 |
| Time since HIV diagnosis (years)a | 6.1 ± 5.6 | 5.7 ± 5.4 | 8.9 ± 6.1 | 0.041 |
| Number of sexual partners in the past 12 monthsa | 1.8 ± 2.4 | 1.8 ± 2.4 | 2.1 ± 2.2 | 0.654 |
| Use of condom during last occurrence of sexual intercourse | 90 (60.8) | 78 (59.1) | 12 (75.0) | 0.894 |
| Injecting drug use | 4 (2.7) | – | 4 (25.0) | <0.001 |
| Smoking drug use | 22 (14.8) | 19 (14.4) | 3 (18.8) | 0.823 |
| Snorting drug use | 24 (16.2) | 19 (14.4) | 5 (31.3) | 0.511 |
| Blood transfusion | 38 (25.6) | 33 (25.0) | 5 (31.3) | 0.910 |
| Tattoo | 43 (29.0) | 35 (26.5) | 8 (50.0) | 0.120 |
| Piercing | 10 (6.7) | 7 (5.3) | 3 (18.8) | 0.123 |
| Surgery | 98 (66.2) | 82 (62.1) | 16 (100.0) | 0.008 |
| Endoscopy | 34 (22.9) | 32 (24.2) | 2 (12.5) | 0.941 |
| Sharing toothbrushes | 19 (12.8) | 17 (12.9) | 2 (12.5) | 0.928 |
| Sharing sharp objects (in salon, manicure, pedicure, barber and personal care) | 61 (41.2) | 57 (43.2) | 4 (25.0) | 0.187 |
| Working in the health service | 11 (7.4) | 9 (6.8) | 2 (12.5) | 0.686 |
| STD history | 46 (31.0) | 38 (28.8) | 8 (50.0) | 0.265 |
| HAART use | 111 (75.0) | 99 (75.0) | 12 (75.0) | 0.847 |
Note: Variables expressed as number (percentage) or mean ± standard deviation.
STD, sex transmitted disease; HAART, highly active antiretroviral therapy.
Bold values are those statistically significant (p<0.05), but this emphasis can be omitted.
a
Totals do not coincide due to lack of data from certain participants in the study.
b
Multiple response.